A Multi Marker Evaluation of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 2

Abstract

Background: Rheumatoid arthritis (RA), an inflammatory joint disease, is also associated with systemic effects. Patients with RA have an increased risk of morbidity and mortality that is mainly attributable to cardiovascular disease (CVD). Both traditional and novel risk factors are implicated in causing the increased CVD risk in RA patients. Materials and Method: Forty six RA patients, diagnosed with RA as per 1987 revised ARA criteria and forty six age and sex matched healthy controls were studied. Fasting lipid profile (Total cholesterol, triglycerides, HDL cholesterol), inflammatory markers (high sensitivity C reactive protein [hsCRP] and fibrinogen), oxidant and antioxidant markers (malondialdehyde [MDA] and ferric reducing ability of plasma [FRAP]), uric acid, homocysteine and Nitric oxide (NO) were measured in all subjects. Results: Among the traditional lipid parameters studied, triglycerides were increased in RA patients compared to controls (p=0.023). Both hsCRP (p<0.001) and fibrinogen (p=0.006) were elevated in RA patients than in controls. MDA levels were increased (p<0.001) and FRAP levels decreased (p<0.001) in patients with RA compared to controls. Uric acid and homocysteine levels showed no significant difference between RA patients and controls. Nitric oxide levels were increased in RA patients when compared with controls (p=0.030). Conclusion: Patients with rheumatoid arthritis were found to have an increased risk of CVD as evidenced by increased triglyceride levels, increased inflammatory markers, presence of oxidative stress. Hence, management of these patients should also include evaluation of CVD risk besides treatment of joint symptoms.

Authors and Affiliations

Krishna Barla, Kiranmayi S. Vinapamula, Siddhartha kumar Bhattaram, Aparna R. Bitla, Suchitra M. Manohar

Keywords

Related Articles

Distribution of subclinical thyroid disease and other primary thyroid disorders in a tertiary care center

Background: Thyroid dysfunctions are common endocrine problems. They account for a considerable morbidity and mortality. Subclinical thyroid diseases especially subclinical hypothyroidism is a common clinical entity that...

Creatine kinase & lactate dehydrogenase activity in patients with hypothyroidism

Thyroid hormone exerts its action in all tissues and modulates several metabolic activity. Alteration in thyroid levels has a profound effect on skeletal muscle The aim of this study is to study the association of thyroi...

Gamma Glutamyl Transferase in Impaired Glucose tolerance and type 2 Diabetes Mellitus

Aim: The current study was undertaken, 1. to compare serum levels gamma glutamy transferase in among three groups namely type II diabetes mellitus, impaired glucose tolerance and apparently healthy controls; 2. to measur...

A comparative study on the estimation of serum Creatinine levels by Jaffe's and Enzymatic methods at different levels of serum Bilirubin

In the present study, based upon their total serum bilirubin values ranging from 0.3-30.8 mg/dl, 47 patients visiting OPD and IPD of HIMS were divided into five groups. Their serum creatinine levels were estimated by the...

MDM2 promoter polymorphism (rs2279744) and serum estrogen level are associated with increased risk of epithelial ovarian cancer: A case-control study

Introduction Epithelial ovarian cancer EOC is most common malignancy affecting Indian women One of the transcriptional targets of p53 is human homolog of Murine Double Minute 2 Oncogene MDM2 which is a crucial negative r...

Download PDF file
  • EP ID EP296818
  • DOI 10.18231/2394-6377.2017.0033
  • Views 95
  • Downloads 0

How To Cite

Krishna Barla, Kiranmayi S. Vinapamula, Siddhartha kumar Bhattaram, Aparna R. Bitla, Suchitra M. Manohar (2017). A Multi Marker Evaluation of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis. International Journal of Clinical Biochemistry and Research, 4(2), 140-144. https://www.europub.co.uk/articles/-A-296818